Viatris Inc (VTRS) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Total Revenue Chart for Viatris Inc

Viatris Inc (VTRS) revenue for FY2025 was USD 14.3B, a -3.0% change from FY2024. Viatris Inc's revenue grew from USD 80.8M in 1985 to USD 14.3B in 2025 (17597.9% over 40 years). Earnings per share grew from USD 0.92 in 2016 to USD 1.71 in 2022 (85.1%). Revenue compound annual growth rate: 5-year CAGR of 3.7%, 10-year CAGR of 4.3%, 20-year CAGR of 12.9%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Revenue (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$18.64B
Implied Share Price
$16.23
Enterprise Value
$30.77B
Revenue (TTM)
$14.74B
EBITDA
$4.29B
Profit Margin
-2.79%
Trailing P/E
—
Forward P/E
6.49
Price/Book (MRQ)
1.31
Price/Sales (TTM)
1.26
EV/EBITDA
11.74
EV/Revenue
2.09
Dividend Yield
2.99%
Book Value
$12.59
Free Cash Flow (FY2025)
$1.94B
Free Cash Flow Yield
10.39%

Snapshot as of 16th August 2026 — not point-in-time controlled, may lag the live market by a few days.